Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

International Journal of Endocrinology
Volume 2015 (2015), Article ID 924387, 6 pages
http://dx.doi.org/10.1155/2015/924387
Research Article

Ferritin as a Risk Factor for Glucose Intolerance amongst Men and Women Originating from the Indian Subcontinent

1University of Birmingham Centre for Cardiovascular Sciences, Sandwell and West Birmingham Hospitals NHS Trust, West Midlands B18 7QH, UK
2Medical School, University of Nottingham, Nottingham NG7 2UH, UK
3Primary Care Clinical Sciences, University of Birmingham, West Midlands B15 2TT, UK

Received 12 June 2015; Accepted 22 July 2015

Academic Editor: Javier Salvador

Copyright © 2015 Elizabeth A. Hughes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Jehn, E. Guallar, J. M. Clark et al., “A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study,” American Journal of Epidemiology, vol. 165, no. 9, pp. 1047–1054, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. N. G. Forouhi, A. H. Harding, M. Allison et al., “Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study,” Diabetologia, vol. 50, no. 5, pp. 949–956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Jiang, J. E. Manson, J. B. Meigs, J. Ma, N. Rifai, and F. B. Hu, “Body iron stores in relation to risk of type 2 diabetes in apparently healthy women,” The Journal of the American Medical Association, vol. 291, no. 6, pp. 711–717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. N. F. Olivieri and G. M. Brittenham, “Iron-chelating therapy and the treatment of thalassemia,” Blood, vol. 89, no. 3, pp. 739–761, 1997. View at Google Scholar · View at Scopus
  5. K. Dmochowski, D. T. Finegood, W. Francombe, B. Tyler, and B. Zinman, “Factors determining glucose tolerance in patients with thalassemia major,” Journal of Clinical Endocrinology and Metabolism, vol. 77, no. 2, pp. 478–483, 1993. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Cade, J. A. Moreton, B. O'Hara et al., “Diet and genetic factors associated with iron status in middle-aged women,” The American Journal of Clinical Nutrition, vol. 82, no. 4, pp. 813–820, 2005. View at Google Scholar · View at Scopus
  7. L. Qi, R. M. van Dam, K. Rexrode, and F. B. Hu, “Heme iron from diet as a risk factor for coronary heart disease in women with type 2 diabetes,” Diabetes Care, vol. 30, no. 1, pp. 101–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. H. King, R. E. Aubert, and W. H. Herman, “Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections,” Diabetes Care, vol. 21, no. 9, pp. 1414–1431, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. K. Cruickshank, D. G. Beevers, V. L. Osbourne, R. A. Haynes, J. C. Corlett, and S. Selby, “Heart attack, stroke, diabetes, and hypertension in West Indians, Asians, and whites in Birmingham, England,” British Medical Journal, vol. 25, no. 281, p. 1108, 1980. View at Google Scholar · View at Scopus
  10. N. P. S. Verma, S. P. Mehta, S. Madhu, H. M. Mather, and H. Keen, “Prevalence of known diabetes in an urban Indian environment: the Darya Ganj diabetes survey,” British Medical Journal, vol. 293, no. 6544, pp. 423–424, 1986. View at Publisher · View at Google Scholar · View at Scopus
  11. G. K. Dowse, H. Gareeboo, P. Z. Zimmet et al., “High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group,” Diabetes, vol. 39, no. 3, pp. 390–396, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. J. K. Cruickshank, J. Cooper, M. Burnett, J. Macduff, and U. Drubra, “Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure,” The Lancet, vol. 338, no. 8771, pp. 842–847, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. K. L. Ramaiya, E. Denver, and J. S. Yudkin, “Diabetes, impaired glucose tolerance and cardiovascular disease risk factors in the Asian Indian Bhatia community living in Tanzania and in the United Kingdom,” Diabetic Medicine, vol. 12, no. 10, pp. 904–910, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. J. V. Patel, A. Vyas, D. Prabhakaran et al., “Nonesterified fatty acids as mediators of glucose intolerance in Indian Asian populations,” Diabetes Care, vol. 28, no. 6, pp. 1505–1507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Fischbacher, R. Bhopal, S. Patel, M. White, N. Unwin, and K. G. M. M. Alberti, “Anaemia in Chinese, South Asian, and European populations in Newcastle upon Tyne: cross sectional study,” British Medical Journal, vol. 322, no. 7292, pp. 958–959, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. J. V. Patel, A. Vyas, J. K. Cruickshank et al., “Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India,” Atherosclerosis, vol. 185, no. 2, pp. 297–306, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. WHO Study Group, “Diabetes mellitus,” World Health Organization Technical Report Series 727, 1985. View at Google Scholar
  18. M. Yamamoto, M. Iwasa, K. Iwata et al., “Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease,” Journal of Gastroenterology and Hepatology, vol. 22, no. 4, pp. 498–503, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Dandona, A. Aljada, and A. Bandyopadhyay, “Inflammation: the link between insulin resistance, obesity and diabetes,” Trends in Immunology, vol. 25, no. 1, pp. 4–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Jiang, J. Ma, A. Ascherio, M. J. Stampfer, W. C. Willett, and F. B. Hu, “Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study,” American Journal of Clinical Nutrition, vol. 79, no. 1, pp. 70–75, 2004. View at Google Scholar · View at Scopus
  21. Y. Ren, H. Tian, X. Li, J. Liang, and G. Zhao, “Elevated serum ferritin concentrations in a glucose-impaired population and in normal glucose tolerant first-degree relatives in familial type 2 diabetic pedigrees,” Diabetes Care, vol. 27, no. 2, pp. 622–623, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-H. Kim, H.-K. Kim, S. J. Bae, J.-Y. Park, and K.-U. Lee, “Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women,” Metabolism: Clinical and Experimental, vol. 60, no. 3, pp. 414–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Niederau, M. Berger, W. Stremmel et al., “Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?” Diabetologia, vol. 26, no. 6, pp. 441–444, 1984. View at Publisher · View at Google Scholar · View at Scopus
  24. J. G. Wilson, J. H. Lindquist, S. C. Grambow, E. D. Crook, and J. F. Maher, “Potential role of increased iron stores in diabetes,” The American Journal of the Medical Sciences, vol. 325, no. 6, pp. 332–339, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Hevi and S. L. Chuck, “Ferritins can regulate the secretion of apolipoprotein B,” The Journal of Biological Chemistry, vol. 278, no. 34, pp. 31924–31929, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. K. A. Rashid, S. Hevi, Y. Chen, F. L. Cahérec, and S. L. Chuck, “A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B,” The Journal of Biological Chemistry, vol. 277, no. 24, pp. 22010–22017, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Juanola-Falgarona, J. Cándido-Fernández, J. Salas-Salvadó et al., “Association between serum ferritin and osteocalcin as a potential mechanism explaining the iron-induced insulin resistance,” PLoS ONE, vol. 8, no. 10, Article ID e76433, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Farmaki, N. Angelopoulos, G. Anagnostopoulos, E. Gotsis, G. Rombopoulos, and G. Tolis, “Effect of enhanced iron chelation therapy on glucose metabolism in patients with β-thalassaemia major,” British Journal of Haematology, vol. 134, no. 4, pp. 438–444, 2006. View at Publisher · View at Google Scholar · View at Scopus